Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines.
- Resource Type
- Article
- Source
- International Journal of Molecular Medicine; Aug2019, Vol. 44 Issue 2, p437-446, 10p
- Subject
- Language
- ISSN
- 11073756